A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial is studying the safety and potential anti-tumor activity of an investigational drug called ARV-393 in patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma (R/R NHL) to determine if ARV-393 may be a possible treatment option. ARV-393 is thought to work by breaking down a protein present in many types of non-Hodgkins lymphomas, which may prevent, slow or stop tumor growth. This is the first time ARV-393 will be used by people. The investigational drug will be given as an oral tablet.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony nawrotowy lub oporny chłoniak nieziarniczy, który nie reaguje na dotychczasowe leczenie
- •Wcześniejsze leczenie co najmniej dwoma rodzajami chemioterapii (w tym rituximabem)
- •Nienadający się do innych znanych terapii selon oceny lekarza
- •Co najmniej jeden widoczny na obrazach guz o wielkości ponad 1,5 cm
- •Dobry ogólny stan zdrowia (skala ECOG 0 lub 1)
- •Prawidłowe funkcje nerek, wątroby i szpiku kostnego
✗ Disqualifies
- •Historia zwiększonego poziomu eozynofilów we krwi lub zespół hipereozynofilii
- •Wcześniejsza transplantacja komórek macierzystych lub organów
- •Leczenie terapią CAR-T w ciągu ostatnich 60 dni
- •Inny nowotwór w ciągu ostatnich 3 lat (poza rakami skóry)
- •Zawał serca w ciągu ostatnich 6 miesięcy
- •Rodzinna historia zespołu wydłużonego QT
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 26, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (19)
Clinical Trial Site
New Haven, United States
Clinical Trial Site
Miami, United States
Clinical Trial Site
Detroit, United States
Clinical Trial Site
New Brunswick, United States
Clinical Trial Site
New York, United States
Clinical Trial Site
New York, United States
Clinical Trial Site
Cleveland, United States
Clinical Trial Site
Nashville, United States
Clinical Trial Site
Houston, United States
Clinical Trial Site
Charlottesville, United States
Clinical Trial Site
Toronto, Canada
Clinical Trial Site
Montreal, Canada
Clinical Trial Site
Copenhagen, Denmark
Clinical Trial Site
Odense C, Denmark
Clinical Trial Site
El Palmar, Spain
Clinical Trial Site
Pamplona, Spain
Clinical Trial Site
Barcelona, Spain
Clinical Trial Site
Madrid, Spain
Clinical Trial Site
Salamanca, Spain
Trial contact
Arvinas Operations, Inc.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/27/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.